Kerala Ayurveda (BOM:530163) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


BOM:530163 Kerala Ayurveda Ltd BOM:530163
47 GF Score
Price ₹182.00
GF Value ₹318.73
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Kerala Ayurveda Research & Development?

Kerala Ayurveda BOM:530163 -1.62% 47 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:530163 with a GF Score™ of 47/100 and a GF Value™ of ₹318.73 (Possible Value Trap). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Kerala Ayurveda's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Kerala Ayurveda  (BOM:530163) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Kerala Ayurveda Research & Development Related Terms

Kerala Ayurveda Research & Development Historical Data

* Premium members only.

The historical data trend for Kerala Ayurveda's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kerala Ayurveda Research & Development Chart

Kerala Ayurveda Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.16 3.62 1.53 1.26 0.00

Kerala Ayurveda Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:530163
47GF Score
Kerala Ayurveda Ltd BOM:530163
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kerala Ayurveda Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Kerala Ayurveda (BOM:530163) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Kerala Ayurveda and its competitors.
Is Kerala Ayurveda's Research & Development too high?
Kerala Ayurveda's current Research & Development is ₹0 Mil. Overall, Kerala Ayurveda has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kerala Ayurveda's Research & Development compare to ZTS and UTHR?
Kerala Ayurveda's Research & Development of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Kerala Ayurveda and its competitors. Kerala Ayurveda's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kerala Ayurveda stock overvalued right now?
Based on GuruFocus' analysis, Kerala Ayurveda (BOM:530163) is currently considered Possible Value Trap. The stock's GF Value™ is ₹318.73, compared to a current price of ₹182.00 — trading 42.9% below its estimated fair value. The current Research & Development is ₹0 Mil. Kerala Ayurveda's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Kerala Ayurveda (BOM:530163), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kerala Ayurveda (BOM:530163) Overvalued in 2026?

Based on GuruFocus' analysis, Kerala Ayurveda stock appears to be undervalued. The current stock price of ₹182.00 is trading 42.9% below its estimated GF Value™ of ₹318.73. GuruFocus considers Kerala Ayurveda to be Possible Value Trap.

Key valuation signals for BOM:530163:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹318.73 vs. price of ₹182.00 (42.9% below fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the BOM:530163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kerala Ayurveda Business Description

Address XV/551, Athani Post, Nedumbassery, Ernakulam District, Ernakulam, KL, IND, 683585
Kerala Ayurveda Ltd is engaged in producing and selling ayurvedic products and providing healthcare services. The company offers ayurvedic medicine products for diabetes and heart health, skin and hair care, kids' health, women's care, men's care, gastro care, respiratory and allergy, general healthcare, massage oils, renal care, and joint care. It provides services through wellness clinics, resorts, hospitals, and academies. The company has only one reportable business segment, i.e., Full-spectrum Ayurvedic wellness. It generates maximum revenue from the sale of products. Geographically, the company generates maximum revenue from its business in India and also has some exposure to other markets.
47GF Score

Get the complete analysis for BOM:530163

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹182.00
Price
₹318.73
GF Value